Tangramed Biotech and Biomunex Pharmaceuticals Announce AI-Driven Research Collaboration

May 26

1 min read

Updated: 16 hours ago

Tangramed Biotech and Biomunex Pharmaceuticals have entered into a research collaboration combining AI-powered target-combination discovery with Biomunex's proprietary BiXAb® antibody platform technologies.

Biomunex Pharmaceuticals and Tangramed Biotech research collaboration

The collaboration aims to identify and prioritize novel target pairs to support the discovery of differentiated cancer immunotherapies.

Read the official press release →

Visit Biomunex Pharmaceuticals →